pH-sensitive release of nitric oxide gas using peptide-graphene co-assembled hybrid nanosheets.

cardiovascular disease co-assembly dipeptides graphene oxide nanohybrids nitric oxide release pH responsiveness

Journal

Nitric oxide : biology and chemistry
ISSN: 1089-8611
Titre abrégé: Nitric Oxide
Pays: United States
ID NLM: 9709307

Informations de publication

Date de publication:
15 Apr 2024
Historique:
received: 14 03 2024
revised: 04 04 2024
accepted: 11 04 2024
medline: 18 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: aheadofprint

Résumé

Nitric oxide (NO) donating drugs such as organic nitrates have been used to treat cardiovascular diseases for more than a century. These donors primarily produce NO systemically. It is however sometimes desirable to control the amount, location, and time of NO delivery. We present the design of a novel pH-sensitive NO release system that is achieved by the synthesis of dipeptide diphenylalanine (FF) and graphene oxide (GO) co-assembled hybrid nanosheets (termed as FF@GO) through weak molecular interactions. These hybrid nanosheets are characterised by using X-ray diffraction, Raman spectroscopy, Fourier transform infrared spectroscopy, zeta potential measurements, X-ray photoelectron spectroscopy, scanning and transmission electron microscopies. The weak molecular interactions, which include electrostatic, hydrogen bonding and π-π stacking, are pH sensitive due to the presence of carboxylic acid and amine functionalities on GO and the dipeptide building blocks. Herein, we demonstrate that this formulation can be loaded with NO gas with the dipeptide acting as an arresting agent to inhibit NO burst release at neutral pH; however, at acidic pH it is capable of releasing NO at the rate of up to 0.6 μM per minute, comparable to the amount of NO produced by healthy endothelium. In conclusion, the innovative conjugation of dipeptide with graphene can store and release NO gas under physiologically relevant concentrations in a pH-responsive manner. pH responsive NO-releasing organic-inorganic nanohybrids may prove useful for the treatment of cardiovascular diseases and other pathologies.

Identifiants

pubmed: 38631610
pii: S1089-8603(24)00051-X
doi: 10.1016/j.niox.2024.04.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Authors declare no conflict of interest.

Auteurs

Tanveer A Tabish (TA)

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Oxford, OX3 7BN, United Kingdom. Electronic address: tanveer.tabish@cardiov.ox.ac.uk.

Jiamin Xu (J)

Department of Materials and London Centre for Nanotechnology, Imperial College London, London, SW7 2AZ, United Kingdom.

Christopher K Campbell (CK)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), The Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, United Kingdom.

Manzar Abbas (M)

Department of Chemistry, Khalifa University of Science and Technology, P.O. Box, 127788, Abu Dhabi, United Arab Emirates.

William K Myers (WK)

Centre for Advanced Electron Spin Resonance (CAESR), Inorganic Chemistry Laboratory, Department of Chemistry, University of Oxford, Oxford, OX1 3QR, United Kingdom.

Pravin Didwal (P)

Department of Materials, University of Oxford, Parks Road, Oxford, OX1 3PH, United Kingdom.

Dario Carugo (D)

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), The Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, United Kingdom.

Fang Xie (F)

Department of Materials and London Centre for Nanotechnology, Imperial College London, London, SW7 2AZ, United Kingdom.

Mark J Crabtree (MJ)

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Oxford, OX3 7BN, United Kingdom; Department of Biochemical Sciences, School of Biosciences and Medicine, University of Surrey, Guildford, GU2 7XH, United Kingdom.

Eleanor Stride (E)

Institute of Biomedical Engineering (IBME), Department of Engineering Science, University of Oxford, Oxford OX3 7LD, United Kingdom.

Craig A Lygate (CA)

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Oxford, OX3 7BN, United Kingdom.

Classifications MeSH